Roche acquires US-German co Therapeutic Human Polyclonals for 56.6 mln usd |
|
|
|
Published
:
Mon, 02 Apr 2007 07:06
|
ZURICH (AFX) - Roche Holding AG announced it has acquired Therapeutic Human Polyclonals Inc (THP), a privately-owned biotechnology company based in California and Germany, for 56.5 mln usd in cash.The company, which is focusing on antibody research, will be integrated into Roche's pharma centre of excellence for protein research in Penzberg, Germany, the Basel-based drugs maker said.'We are delighted about this acquisition as it builds on our strength in therapeutic antibodies,' said Jonathan Knowles, Head of Global Research.The development of therapeutic proteins and antibodies remains a major emphasis at Roche, the company said.afx.zurich@afxnews.comat/lamCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
Print this Story
Japan's Astellas in licensing deal with Regeneron for antibody devt technology 